The animal care brands of EBOS – Black Hawk, Vitapet, and Lyppard – have all maintained strong growth over the past year.
In the company’s FY2022 results, it was reported the animal care segment generated revenue of $541.3 million and EBIT of $72.6 million, an increase of 8.8 per cent and 15.3 per cent on the prior year.
John Cullity, CEO of EBOS, said that the animal care division had continued its strong first half performance, recording robust growth.
“The strength and diversity of our portfolio of businesses is reflected as both our Healthcare and Animal Care segments contributed strongly to the overall result and successfully executed our strategy of pursuing both organic and inorganic growth.
“Pet market conditions continue to be strong and our leading brands and divisions have capitalised on this.”
The report stated that the pet care market is supported by well-established trends including the humanisation of pets and premiumisation of products, and that these trends have been supported by changed household behaviours as a result of COVID-19.
The construction and commissioning of a new state of the art premium pet food manufacturing facility in Parkes, NSW has been completed, resulting in steadily increasing commercial production rates.
“The new facility enhances our local supply chain capabilities and is a competitive advantage in this environment. In response to increased consumer demand for Black Hawk, we will be commencing a third shift at the site earlier than initially projected,” stated the report.
The launch of new Black Hawk treats and puppy food products capitalised on the brand’s strength and so far the performances of these products are in line with expectations.
As a whole, EBOS reported revenue of $10.7 billion, exceeding $10 billion for its first time, and up 16.6 per cent on the previous year.
“It is pleasing to report another record profit for EBOS for FY22, our 100th year of operation. Our double-digit revenue and earnings growth reflects a continuation of the strong first half that we announced in February 2022. In addition, throughout the year we made investments that position the Group for continued growth in the future,” said Cullity.